Navigation Links
Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information
Date:3/29/2011

NEW HAVEN, Conn., March 29, 2011 /PRNewswire/ -- USChina Channel LLC announced today:

On March 11, 2011, Bill Guo, Chairman of Commonwealth Biotechnologies Inc. ("CBI") filed Form 8-k of SEC, to announce the detail of 2011 Annual Shareholder Vote & Meeting. The vote process is going very well.

We already have shareholders representing over 3 million shares of common stock made the vote. Followings are the interim vote results for the four proposals:PROPOSAL 001 ELECTION OF DIRECTOR: BILL GUOFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

366,658

21,848

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

2,982,351

21,848

0% OF VOTED

99.27%

0.72%

0.00%% OF OUTSTANDING

24.66%

0.18%

0.00%PROPOSAL 002 REVISE OF ARTICLE OF CBI & ACCEPT MIN. 1 MEMBER OF DIRECTORS OF BOARDFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

365,658

22,848

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

2,981,351

22,848

0% OF VOTED

99.23%

0.76%

0.00%% OF OUTSTANDING

24.65%

0.18%

0.00%PROPOSAL 003 REVISE OF BYLAWS OF CBI & ACCEPT MIN. 1 MEMBER OF DIRECTORS OF BOARDFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

365,658

22,848

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

2,981,351

22,848

0% OF VOTED

99.23%

0.76%

0.00%% OF OUTSTANDING

24.65%

0.18%

0.00%PROPOSAL 004 SALARY & COMPES. OF NEW DIRECTOR WILL BE $1 PER YEARFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

388,206

300

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

3,003,899

300

0% OF VOTED

99.99%

0.00%

0.00%% OF OUTSTANDING

24.83%

0.00%

0.00%There are 99.99% of the voted shares approved the proposal that the salary and compensation of new director(s) would be $1 per year. To cut the overhead expenses sharply became the whelming demands of the voted shareholders.

These shareholders, who haven't voted, could go to www.proxyvote.com making a vote now. Whether you agree or disagree, your voice is important for CBI which is in a critical status for fighting surviving.

We welcome all shareholders to attend the CBI 2011 Annual Shareholders Meeting, which will be held at 10:00 a.m. EDT, on April 4, 2011. The meeting will be held electronically via telecom.  Here is the url address that has been assigned for your virtual annual meeting: 

http://www.virtualshareholdermeeting.com/CBTE

Shareholders will be able to log onto the above site approximately 15 minutes prior to the meeting to listen to the proceedings, view the annual meeting materials, vote their shares and ask a question if they choose to do so. 

Since we suspended SEC reporting status, shareholders could go to the url address www.otcmarkets.com from CBI trading symbol or name to find the limited communication between company and public.

If you have any question, please contact:

Bill Guo  Address: Venturepharm Towers

USA: C/o Agent: Andrew ChienNo. 3 Jinzhuang, Sijiqing, Haidian District

665 Ellsworth AvenueBeijing, China PC 100089

 New Haven, CT 06511Tel: 86-10-88500088

Tel: 203-8440809Fax: 86-10-88500080

Fax: 8665716313E-mail: la@venturepharm.com

E-mail: uschien@uschinachannel.netWe hired InvestorCom, Inc to do proxy solicitation, and any one could contact them by:

John Glenn Grau, President.  InvestorCom, Inc., www.investor-com.com65 Locust Avenue, Third Floor,  New Canaan, CT   06840P (203) 972-9300 ext. 11   F (203) 966-6478
M (646) 242-041045 Park Avenue, Suite 3900, New York, NY
7P (212) 668-0800
'/>"/>

SOURCE Commonwealth Biotechnologies Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
2. Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members
3. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
4. Epeius Biotechnologies REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA
5. Reportlinker Adds Nanobiotechnologies- applications, markets and companies
6. TriLink BioTechnologies Launches CleanAmp™ 7-deaza-dGTP for GC-rich Target Amplification
7. Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIRE™ Label-Free Detection Technology for Proteomics
8. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
9. TriLink BioTechnologies to Sponsor Take Me Out to the Ballgame, a SAY San Diego Event Benefiting San Diego Families in Need
10. Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives
11. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... A new study ... in frozen and fresh in vitro fertilization (IVF) transfer cycles. The ... IVF success. , After comparing the results from the fresh and frozen transfer ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... Parks Associates announced today that Tom Kerber , Director ... , October 11 in Scottsdale, Arizona . Kerber will ... safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction of ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions ... scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory ...
Breaking Biology Technology:
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
Breaking Biology News(10 mins):